Evaluation of the poly(lactic-co-glycolic acid)/pluronic F127 for injection laryngoplasty in rabbits

• Published in: Otolaryngology-head and neck surgery Vol. 151; no. 5; p. 830
• Main Authors: Lee, Jin Ho, Kim, Dong Wook, Kim, Eun Na, Park, Seok-Won, Kim, Hee-Bok, Oh, Se Heang, Kwon, Seong Keun
• Format: Journal Article
• Language: English
• Published: England 01.11.2014
• Subjects: Animals; Biocompatible Materials - administration & dosage; Injections; Lactic Acid - administration & dosage; Laryngoplasty - methods; Male; Materials Testing; Poloxamer - administration & dosage; Polyglycolic Acid - administration & dosage; Rabbits; Vocal Cords; drug delivery system; injection laryngoplasty; augmentation; Poly(lactic-co-glycolic acid); vocal fold palsy
• ISSN: 1097-6817
• DOI: 10.1177/0194599814549527

Poly(lactic-co-glycolic acid) (PLGA) is an aliphatic polyester and one of the most commonly used synthetic biodegradable polymers for tissue engineering. The objectives of this study were to evaluate the biocompatibility of PLGA/Pluronic F127 in the vocal fold. A randomized, prospective, controlled animal study. University laboratory. We used 18 New Zealand white rabbits, which were divided into 5% PLGA solution (n = 9) and 10% PLGA solution (n = 9) groups. The PLGA/Pluronic F127 solutions were injected into the rabbit vocal fold. Laryngoscopic exams were performed at 1, 4, and 8 weeks after implantation; then larynx specimens were sampled. High-speed video camera examination was performed for functional analysis of vocal mucosa vibration at 8 weeks after implantation. Also, we evaluated the amplitude of the mucosal wave from the laryngeal midline on high-speed recording. Histologic study of larynx specimen was performed at 4 and 8 weeks. All animals survived until the scheduled period. Laryngoscopic analysis showed that both 5% and 10% PLGA/Pluronic F127 maintained after 8 weeks after injection without significant inflammatory response. On functional analysis, high-speed camera examination revealed regular and symmetric contact of vocal fold mucosa without a distorted movement by injected PLGA/Pluronic F127. Histologically, no significant inflammation was observed in the injected vocal fold. As a vocal fold injection material, PLGA/Pluronic F127 showed a good bio-compatibility without significant inflammatory response. Further experiment will follow to elucidate its role for drug or gene delivery into the vocal fold.